Stand Up 2 Cancer September 10th September 8, 2010 Read More In the News BioCentury – Makary: New ultrarare path will provide approval based on ‘plausible mechanism’ In the News The Cancer Letter – Lung-MAP trial for NSCLC expands genomic screening options for patients
In the News BioCentury – Makary: New ultrarare path will provide approval based on ‘plausible mechanism’
In the News The Cancer Letter – Lung-MAP trial for NSCLC expands genomic screening options for patients